Dr. Cameron Ghaffary , MD
Surgery • Galveston, TX
301 University Blvd
Galveston, TX 775550534
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 23, 2014; this date does not establish years in practice.
-
Published CMS data list 5,083 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 81000 — Manual urinalysis test with examination using microscope, non-automated: 949 service units.
- 51798 — Ultrasound measurement of bladder capacity after voiding: 691 service units.
- 99214 — Established patient outpatient office visit: 691 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 28 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,207 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 319 prescription fills, including refills.
- Gemtesa (Vibegron) — 130 prescription fills, including refills.
- Finasteride — 118 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 18 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Surgery in Texas (2024, 1,118 clinicians with data). Median for this group: 149. Middle half: 72 to 277.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,456 in 2020 to 5,083 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
301 University Blvd
Galveston, TX 775550534
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Corpus Christi Urology Group Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Creighton University School Of Medicine
2014
What Public CMS Data Show
Surgery: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
707 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $271,829 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $210,705 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
2,461 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$296,797 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $697.01 across 26 records.
By nature of payment
- Food and Beverage: $697.01 across 26 records.
Reporting-company totals (3 largest of 8)
- Sumitomo Pharma America, Inc.: $255.23 across 10 records.
- ABBVIE INC.: $184.11 across 8 records.
- Agiliti Health, Inc.: $97.32 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
12 years (graduated 2014)
CMS Doctors and Clinicians data list 2014 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2014
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Ghaffary has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Ghaffary as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Galveston and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Surgery in Texas (2024, 1,118 clinicians with data). Median for this group: 149. Middle half: 72 to 277.
Too few clinicians listed under Surgery in Galveston have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Surgery in Texas (2024, 1,118 clinicians with data). Median for this group: $21,080. Middle half: $8,877 to $41,293.
Too few clinicians listed under Surgery in Galveston have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Surgery in Texas (2024, 1,118 clinicians with data). Median for this group: $15,808. Middle half: $6,726 to $32,010.
Too few clinicians listed under Surgery in Galveston have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Surgery in Texas (2024, 942 clinicians with data). Median for this group: 70. Middle half: 30 to 144.
Too few clinicians listed under Surgery in Galveston have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Surgery in Texas (2024, 942 clinicians with data). Median for this group: $499. Middle half: $178 to $1,720.
Too few clinicians listed under Surgery in Galveston have Medicare Part D data for 2024 to compare.
67 active clinicians are listed under Surgery with a practice address in Galveston, TX (2,211 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Galveston
0% of these 67 clinicians have the CMS telehealth indicator.
14.9% of these 67 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 107% from 2,456 in 2020 to 5,083 in 2024.
- 2020: 2,456
- 2021: 3,283
- 2022: 3,783
- 2023: 4,227
- 2024: 5,083
-
Medicare-allowed amount
Medicare-allowed amount increased 76% from $154,190 in 2020 to $271,829 in 2024.
- 2020: $154,190
- 2021: $306,067
- 2022: $329,375
- 2023: $306,733
- 2024: $271,829
-
Paid by Medicare
Paid by Medicare increased 83% from $114,838 in 2020 to $210,705 in 2024.
- 2020: $114,838
- 2021: $236,597
- 2022: $251,343
- 2023: $235,857
- 2024: $210,705
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 105% from 588 in 2020 to 1,207 in 2024.
- 2020: 588
- 2021: 888
- 2022: 925
- 2023: 1,066
- 2024: 1,207
-
30-day fills
30-day fills increased 132% from 1,062 in 2020 to 2,461 in 2024.
- 2020: 1,062
- 2021: 1,598
- 2022: 1,700
- 2023: 2,099
- 2024: 2,461
-
Part D drug cost
Part D drug cost increased 151% from $118,267 in 2020 to $296,797 in 2024.
- 2020: $118,267
- 2021: $168,036
- 2022: $172,646
- 2023: $195,747
- 2024: $296,797
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $746.98 in 2021 to $697.01 in 2025.
- 2021: $746.98
- 2022: $859.33
- 2023: $717.51
- 2024: $857.60
- 2025: $697.01
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 26 records totaling $697.01.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Agiliti Health, Inc. |
Food and Beverage
Cash or cash equivalent
|
Sonablate HIFU | General | $97.32 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $27.76 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $27.39 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $27.27 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
XIAFLEX | General | $27.04 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $26.58 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $26.32 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $26.14 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $25.99 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $25.85 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $25.69 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $25.12 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $25.05 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $24.99 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $24.96 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $24.75 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $24.46 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $23.56 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $23.39 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $22.95 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $22.55 |
| Myriad Genetic Laboratories, Inc. |
Food and Beverage
In-kind items and services
|
PROLARIS | General | $21.75 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $20.26 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $17.07 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $16.73 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2018–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2019–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
81000
Manual urinalysis test with examination using microscope, non-automated
|
949 | 552 | $25.00 | $3.88 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
691 | 435 | $33.15 | $11.05 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
691 | 444 | $365.02 | $127.80 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
645 | 424 | $47.33 | $16.60 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
291 | 238 | $256.13 | $89.93 |
|
36415
Insertion of needle into vein for collection of blood sample
|
278 | 186 | $15.00 | $8.62 |
|
84153
Psa (prostate specific antigen) measurement, total
|
257 | 169 | $105.00 | $17.76 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
245 | 36 | $750.00 | $171.44 |
|
J0696
Injection, ceftriaxone sodium, per 250 mg
|
156 | 34 | $30.00 | $0.44 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
98 | 80 | $663.51 | $236.48 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
98 | 98 | $484.07 | $168.13 |
|
99426
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
|
96 | 24 | $180.27 | $63.26 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
76 | 27 | $172.74 | $63.91 |
|
84402
Testosterone (hormone) level, free
|
67 | 47 | $35.00 | $24.96 |
|
51720
Instillation of anti-cancer drug into bladder
|
54 | 21 | $252.59 | $84.17 |
|
52442
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant
|
52 | 11 | $144.31 | $50.96 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
51 | 36 | $98.61 | $33.76 |
|
J9030
Bcg live intravesical instillation, 1 mg
|
47 | 19 | $250.00 | $2.73 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
38 | 38 | $322.32 | $112.78 |
|
51702
Simple insertion of temporary bladder tube
|
36 | 23 | $178.31 | $61.64 |
|
51725
Simple measurement of pressure of urine flow in bladder
|
35 | 28 | $638.17 | $227.80 |
|
99439
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
|
29 | 23 | $127.24 | $48.83 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
28 | 13 | $227.18 | $79.51 |
|
51701
Insertion of temporary bladder tube
|
20 | 18 | $129.45 | $44.85 |
|
76872
Ultrasound scan of pelvic region through rectum
|
15 | 15 | $290.87 | $72.20 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 319 | 25,098 | $3,319.10 | 149 |
| Gemtesa | Vibegron | 130 | 7,272 | $114,624.88 | 49 |
| Finasteride | Finasteride | 118 | 9,400 | $1,271.56 | 46 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 115 | 815 | $856.34 | 98 |
| Solifenacin Succinate | Solifenacin Succinate | 89 | 5,160 | $3,042.50 | 30 |
| Estradiol | Estradiol | 86 | 6,175 | $6,170.09 | 66 |
| Myrbetriq | Mirabegron | 76 | 4,800 | $71,367.39 | 33 |
| Potassium Citrate Er | Potassium Citrate | 46 | 3,110 | $2,568.93 | 21 |
| Doxycycline Hyclate | Doxycycline Hyclate | 44 | 910 | $514.64 | 40 |
| Tramadol Hcl | Tramadol Hcl | 36 | 250 | $150.59 | 36 |
| Orgovyx | Relugolix | 29 | 990 | $82,617.39 | — |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 649 | $1,051.84 | 22 |
| Cephalexin | Cephalexin | 20 | 1,334 | $670.43 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 133 | $86.47 | 17 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 133 | $110.69 | 15 |
| Levofloxacin | Levofloxacin | 14 | 93 | $64.17 | 13 |
| Gabapentin | Gabapentin | 12 | 780 | $268.69 | — |
| Mirabegron Er | Mirabegron | 12 | 960 | $8,041.08 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208600000X
A general surgeon has expertise related to the diagnosis - preoperative, operative and postoperative management - and management of complications of surgical conditions in the following areas: alimentary tract; abdomen; breast, skin and soft tissue; endocrine system; head and neck surgery; pediatric surgery; surgical critical care; surgical oncology; trauma and burns; and vascular surgery. General surgeons increasingly provide care through the use of minimally invasive and endoscopic techniques. Many general surgeons also possess expertise in transplantation surgery, plastic surgery and cardiothoracic surgery.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20190617001759
TX
1557694957
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Corpus Christi Urology Group Pllc
601 Texan Trl, Corpus Christi, TX 784112548
Phone: 3615614106
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Anesthesiology
Doctor of Medicine (M.D.)
Surgery
Doctor of Medicine (M.D.)
Doctor of Medicine (M.D.)
Surgery - Surgical Oncology
Doctor of Medicine (M.D.)
Surgery - Vascular Surgery
Doctor of Medicine (M.D.)
Surgery - Plastic and Reconstructive Surgery
MDFACS
Career & Practice History
NPI enumerated April 23, 2014.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Surgery Specialists in Galveston
- Dr. Jose Ortiz De Elguea Lizarraga, MD
- Dr. William Mileski, MD
- Dr. Michael Silva, MD
- Dr. Susana Fortich, MD
- Samuel Cass
- Dr. Lance Griffin, MD
Mailing Address
301 University Blvd
Galveston, TX 775550534
Phone: 4097721369